Phathom Pharmaceuticals, Inc. – FDA Inspection, Jul 31, 2026

Record Details

This FDA Inspection record concerns Phathom Pharmaceuticals, Inc., with an inspection on July 31, 2026, issued by the Chicago District Office, covering human drugs.

Company: Phathom Pharmaceuticals, Inc.
Inspection Date: July 31, 2026
Product Type: Human Drugs
Office: Chicago District Office
People: Jeanne J. Thai (Company Rep)
Ruth E. Medcalf (Issuing Officer)

View Company Profile

ID · ebbfff78-0f1d-4a0d-b8cb-c998a4c99542

Inspection Facts

Inspection number: 1328784
FDA center: Human Drugs
Project area: Postmarket Surv. and Epidemiology
Outcome: Form 483 issued, view the record

FDA Citations

21 CFR 314.80(d)Failure to submit scientific article

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Phathom Pharmaceuticals, Inc.

FDA Inspection

Phathom Pharmaceuticals, Inc.July 31, 2026